Etodolac in the management of pain: A clinical review of a multipurpose analgesic

Inflammopharmacology

Volumn 5, Issue 2, 1997, Pages 139-152

  Bellamy, N ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Analgesia; Etodolac; Pain

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; CYCLOOXYGENASE 2; CYCLOSPORIN; DICLOFENAC; DIGOXIN; ETODOLAC; LITHIUM; METHOTREXATE; NAPROXEN; PARACETAMOL; PIROXICAM BETA CYCLODEXTRIN; PLACEBO; WARFARIN; ZOMEPIRAC;

ANALGESIA; ANALGESIC ACTIVITY; ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BURSITIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG TOLERABILITY; DYSMENORRHEA; EPISIOTOMY; GOUT; HUMAN; LOW BACK PAIN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PAIN; PERIARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RADICULAR PAIN; RHEUMATOID ARTHRITIS; SIDE EFFECT; SPORT INJURY; TENDINITIS; TOOTH EXTRACTION;

EID: 0030838904     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-997-0023-8     Document Type: Article

References (31)

1. 1. LG Humber 1987 Etodolac: The chemistry, pharmacology, metabolic dispositon, and clincial profile of a novel anti-inflammatory pyranocarboxylic acid Med Res Rev. 7 l l 28 Humber LG. Etodolac: The chemistry, pharmacology, metabolic dispositon, and clincial profile of a novel anti-inflammatory pyranocarboxylic acid. Med Res Rev. 1987;7(l):l-28.
2. 2. N Zvaifler 1989 A review of the antiarthritic efficacy and safety of etodolac Clin Rheumatol. 8 Suppl l 43 53 2525982 10.1007/BF02214109 Zvaifler N. A review of the antiarthritic efficacy and safety of etodolac. Clin Rheumatol. 1989;8(Suppl l):43–53.
3. 3. JA Balfour MM Buckley 1991 Etodolac: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states Drugs. 42 2 274 99 1717225 1:STN:280:DyaK38%2Fgslehsg%3D%3D 10.2165/00003495-199142020-00008 Balfour JA, Buckley MM. Etodolac: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs. 1991;42(2):274–99.
4. 4. KD Rainsford 1989 The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side effects KD Rainsford Azapropazone: 20 Years of Clinical Use Springer Netherlands Lancaster 31 51 Rainsford KD. The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side effects. In: Rainsford KD, ed. Azapropazone: 20 Years of Clinical Use. Kluwer Academic Publishers, Lancaster. 1989;31–51.
5. 5. HB Kaplan HS Edelson HM Korchak 1984 Effect of non-steroidal anti-inflammatory agents on humana neutrophil function in vitro and in vivo Biochem Pharmacol. 33 371 8 6422946 10.1016/0006-2952(84)90228-4 1:CAS:528:DyaL2cXhvVGntb8%3D Kaplan HB, Edelson HS, Korchak HM et al. Effect of non-steroidal anti-inflammatory agents on humana neutrophil function in vitro and in vivo. Biochem Pharmacol. 1984;33:371–8.
6. 6. KB Glaser 1995 Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (Iodine) Inflammopharmacology. 3 335 45 10.1007/BF02668029 1:CAS:528:DyaK28XhslOlsb0%3D Glaser KB. Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (Iodine). Inflammopharmacology. 1995;3:335–45.
7. 7. P Sirois C Saura H Salari 1984 Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis Inflammation. 8 4 353 64 6240459 10.1007/BF00918212 1:CAS:528:DyaL2MXjvFKgug%3D%3D Sirois P, Saura C, Salari H et al. Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis. Inflammation. 1984;8(4):353–64.
8. 8. DR Brocks F Jamali 1994 Etodolac clinical pharmacokinetics Clin Pharmacokinet. 26 4 259 74 8013160 1:CAS:528:DyaK2cXlt1Cns7o%3D Brocks DR, Jamali F. Etodolac clinical pharmacokinetics. Clin Pharmacokinet. 1994;26(4):259–74.
9. 9. LZ Benet 1994 Pharmacokinetic profile of etodolac in special populations Eur J Rheumatol Inflam. 14 l 15 8 1:STN:280:DyaK2M3mt1OltQ%3D%3D Benet LZ. Pharmacokinetic profile of etodolac in special populations. Eur J Rheumatol Inflam. 1994;14(l):15–8.
10. 10. PA Bacon 1994 Safety profile of etodolac in the elderly population Eur J Rheumatol Inflam. 14 1 19 22 Bacon PA. Safety profile of etodolac in the elderly population. Eur J Rheumatol Inflam. 1994; 14(1): 19-22.
11. 11. M Schattenkirchner 1990 An updated safety profile of etodolac in several thousand patients Eur J Rheumatol Inflamm. 10 56 65 2146132 1:STN:280:DyaK3M%2FjtFKnsA%3D%3D Schattenkirchner M. An updated safety profile of etodolac in several thousand patients. Eur J Rheumatol Inflamm. 1990;10:56–65.
12. 12. Compendium of Pharmaceuticals and Specialties. Toronto, Canadian Pharmaceutical Association. 1996; 1538–9.
13. 13. SA Cooper 1983 Models for clinical assessment of oral analgesics Am J Med. 75 5A 24 9 6359864 10.1016/0002-9343(83)90229-2 1:STN:280:DyaL2c%2FnslSmtQ%3D%3D Cooper SA. Models for clinical assessment of oral analgesics. Am J Med. 1983;75(5A):24–9.
14. 14. R Scott III E Ellis LG Upton 1986 Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain Oral Surg. 66 6 638 42 10.1016/0030-4220(86)90255-0 Scott R, Ellis III E, Upton LG. Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain. Oral Surg. 1986;66(6):638–42.
15. 15. Nelson SL, Bergman SA. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth Prog. 1985:151–6.
16. 16. CE Hutton 1983 The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgery Oral Surg. 56 6 575 80 6228772 10.1016/0030-4220(83)90070-1 1:STN:280:DyaL2c%2FpsVCqsw%3D%3D Hutton CE. The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgery. Oral Surg. 1983;56(6):575–80.
17. 17. GW Gaston RD Mallow JE Frank 1984 The efficacy of etodolac for patients with pain following oral surgery J Oral Maxillofac Surg. 42 362 66 6232359 1:STN:280:DyaL2c7oslyitQ%3D%3D 10.1016/S0278-2391(84)80007-5 Gaston GW, Mallow RD, Frank JE. The efficacy of etodolac for patients with pain following oral surgery. J Oral Maxillofac Surg. 1984;42:362–66.
18. 18. JA Giglio RL Campbell 1986 Comparison of etodolac, zomepirac, and placebo for relief of pain after oral surgery J Oral Maxillofac Surg. 44 765 70 2944997 1:STN:280:DyaL2s%2FhtFSnug%3D%3D 10.1016/0278-2391(86)90150-3 Giglio JA, Campbell RL. Comparison of etodolac, zomepirac, and placebo for relief of pain after oral surgery. J Oral Maxillofac Surg. 1986;44:765–70.
19. 19. GW Gaston RD Mallow JE Frank 1986 Comparison of etodolac, aspirin and placebo for pain after oral surgery Pharmacotherapy. 6 5 199 204 2948162 1:STN:280:DyaL2s%2FptF2isQ%3D%3D Gaston GW, Mallow RD, Frank JE. Comparison of etodolac, aspirin and placebo for pain after oral surgery. Pharmacotherapy. 1986;6(5):199–204.
20. 20. L Fliedner M Levsky H Kechejian 1984 Analgesia with etodolac in oral postsurgical pain Curr Ther Res. 36 l 33 45 Fliedner L, Levsky M, Kechejian H. Analgesia with etodolac in oral postsurgical pain. Curr Ther Res. 1984;36(l):33–45.
21. 21. Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol Int. 1990;10(Suppl):9–16.
22. 22. M. Mizraji 1990 Clinical response to etodolac in the management of pain Eur J Rheumatol Inflamm. 10 10 35 43 1699764 1:STN:280:DyaK3M%2FjtFKguw%3D%3D Mizraji M. Clinical response to etodolac in the management of pain. Eur J Rheumatol Inflamm. 1990;10(10):35–43.
23. 23. L Versichelen P Bilsback G Roily 1982 Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo Int J Clin Pharmacol Ther Toxicol. 20 5 236 9 6212554 1:STN:280:DyaL383jvVemtg%3D%3D Versichelen L, Bilsback P, Roily G et al. Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo. Int J Clin Pharmacol Ther Toxicol. 1982;20(5):236–9.
24. 24. P Bilsback G Roily L Versichelen 1982 Etodolac in postsurgical pain: Double-blind, dose-ranging efficacy study with aspirin and placebo Cardiol Meas Anaesth. 2 257 60 Bilsback P, Roily G, Versichelen L et al. Etodolac in postsurgical pain: Double-blind, dose-ranging efficacy study with aspirin and placebo. Cardiol Meas Anaesth. 1982;2:257–60.
25. 25. G Roily P Bilsback L Versichelen 1982 Etodolac in postoperative pain: a double-blind study with aspirin and placebo Br J Anaesth. 54 250 l Roily G, Bilsback P, Versichelen L et al. Etodolac in postoperative pain: a double-blind study with aspirin and placebo. Br J Anaesth.1982;54:250-l.
26. 26. E Friedrich 1983 A comparison of etodolac (Ultradol) with aspirin and placebo in patients with episiotomy pain CurrTherap Res. 33 l 100 7 Friedrich E. A comparison of etodolac (Ultradol) with aspirin and placebo in patients with episiotomy pain. CurrTherap Res. 1983;33(l):100–7.
27. 27. M D’Hooghe 1992 Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries Clin Ther. 14 4 507 16 1388091 1:STN:280:By2H3crhtVI%3D D’Hooghe M. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clin Ther. 1992;14(4):507–16.
28. 28. CJ Menkes 1990 Scapulo-humeral periarthritis: efficacy, safety and therapeutic benefit of etodolac (600 mg/ daily) versus piroxicam (40/20 mg/daily) Rhumatologie. 42 7a 207 12 Menkes CJ. Scapulo-humeral periarthritis: efficacy, safety and therapeutic benefit of etodolac (600 mg/ daily) versus piroxicam (40/20 mg/daily). Rhumatologie. 1990;42(7a):207–12.
29. 29. D Bontoux 1990 Lumbo-radiculalgia: efficacy, safety and therapeutic benefit of etodolac (600 mg/daily) versus diclofenac (150 mg/daily) and placebo Rheumatologie. 42 7a 213 18 Bontoux D. Lumbo-radiculalgia: efficacy, safety and therapeutic benefit of etodolac (600 mg/daily) versus diclofenac (150 mg/daily) and placebo. Rheumatologie. 1990;42(7a):213–18.
30. 30. L Davoli G Ciotti M Biondi M Passeri 1989 Piroxicam-beta-cyclodextrin in the treatment of low-back pain CurrTher Res. 46 5 940 7 Davoli L, Ciotti G, Biondi M, Passeri M. Piroxicam-beta-cyclodextrin in the treatment of low-back pain. CurrTher Res. 1989;46(5):940–7.
31. 31. Souza A Zecchi de M Tacla R Hegg 1991 Etodolac in Primary dsysmenorrhoea J Bras Ginecol 101 451 9 Zecchi de Souza A Tacla M, Hegg R et al Etodolac in Primary dsysmenorrhoea. J Bras Ginecol 1991;101:451–9.